Who to call at Vir Biotechnology, Inc., and when
Fundz watches for the moments Vir Biotechnology, Inc. starts buying, and tells you who to reach.
- An alert the day Vir Biotechnology, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vir Biotechnology, Inc., from your own LinkedIn network
Vir Biotechnology, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
vir.bioAI Executive Summary
AI-powered analysis of 8-K filing content
Vir Biotechnology appointed Aziz Sawaf as Executive Vice President and Chief Financial Officer effective October 5, 2026, while Brent Sabatini transitions from interim CFO to Senior Vice President and Chief Accounting Officer. This leadership change in financial management could influence the company's strategic financial direction.
Key Takeaways
Aziz Sawaf, with credentials including MBEE, MBA, and CFA, assumes the permanent CFO role, ending the interim period under Brent Sabatini
Brent Sabatini retains a senior financial role as Chief Accounting Officer, ensuring continuity in accounting operations
2 more takeaways
Related Filings (3)
3 more filings from Vir Biotechnology, Inc. in the last 90 days
Filing Overview
What This Means
Vir Biotechnology, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.